A federal appeals court ruled that St. Francis Medical Center's exclusive contracts with commercial insurers did not violate antitrust laws by keeping other Peoria, Ill., hospitals out of their provider networks.
The Florida Supreme Court ruled that caps on pain-and-suffering damages in medical malpractice lawsuits are unconstitutional.
A federal judge has ordered that the Illinois comptroller negotiate with Medicaid providers to ensure they collect their share of Illinois' $14.9 billion in unpaid bills.
A U.S. Supreme Court decision on Monday preserved faith-based hospitals' exemption from federal pension regulations, but the debate rages on. Now the fight turns to the definition of a "principal purpose" organization.
The high court has unanimously revived a 35-year-old federal practice exempting faith-based hospitals from complying with federal pension regulations.
Pharmacy benefit manager Express Scripts sued a company that develops an emergency drug for opioid overdoses, escalating the ongoing debate on who should be held accountable for drug price hikes.
As insurers sweat over whether the Trump administration will continue funding cost-sharing subsidies for low-income enrollees, 16 state attorneys general have asked a federal appeals court to let them intervene in a legal case to keep those payments flowing.
The Cherokee Nation claims the companies should have prevented rather than profited from the opioid epidemic and the mass distribution of addictive pain pills.
This is the first time the credentials verification company has taken on financial partners.
Federal prosecutors on Thursday charged a former Valeant Pharmaceuticals executive and the ex-CEO of a specialty pharmacy for masterminding a multimillion fraud and kickback scheme that promoted the pharmacy's business for their own personal gain.
WellCare Health Plans has entered agreements that cap costly legal expenses for two former top executives convicted of defrauding Medicaid in a case that started nearly a decade ago. The settlements also allow the executives to cash in stock.
Hostilities are intensifying in the misbegotten matchup of Abbott Laboratories and Alere. The two medical products companies haven't stopped fighting since shortly after Abbott agreed in January to buy Alere for $5.8 billion.